In mouse models of obesity (diet-induced obesity: DIO), levels of FGF15 (the mouse ortholog of human FGF19) are reduced and in humans, serum levels of FGF19 are found to be significantly reduced in patients with type 2 diabetes
That is exactly what researchers are discovering about how GLP-1 drugs affect blood pressure
Ivan Rusilko on The Lifestyle Medicine Podcast to explain why most people aren't broken they're unbalanced
Consequently, this reduces barrier resistance, allowing improved therapeutic penetration, which offers multiple benefits, including non-invasiveness, easy application, and improved patient compliance [35]
10.1001/archinte.166.10.1092 38
This may improve its stability and support healthy glutathione levels within the body